T3D3682 - Dihydrocytochalasin B
| Record Information | |
|---|---|
| Version | 1.0 |
| Creation Date | 2010-04-17 21:57:45 UTC |
| Update Date | 2013-04-25 08:48:34 UTC |
| Accession Number | T3D3682 |
| Identification | |
| Common Name | Dihydrocytochalasin B |
| Description | Cytochalasins are mycotoxins that have the ability to bind to actin filaments and block polymerization and the elongation of actin. As a result, they can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. Cytochalasins also have the ability to permeate cell membranes, prevent cellular translocation, cause cells to enucleate, and affect other aspects of biological processes unrelated to actin polymerization. Dihydrocytochalasin B is a semi-synthetic derivative of cytochalasin B and is a useful probe for studying cytochalasin binding sites. (W713, W714, W715, W718) |
| Compound Type |
|
| Chemical Structure |
|
| Synonyms | Not Available |
| Chemical Formula | C28H37NO5 |
| Average Molecular Weight | 467.5971 |
| Monoisotopic Molecular Weight | 467.267173299 |
| Chemical IUPAC Name | 15-benzyl-4,12-dihydroxy-8,14-dimethyl-13-methylidene-3H,4H,5H,6H,7H,8H,9H,12H,14H,14aH,15H,16H,17bH-oxacyclotrideca[3,2-e]isoindole-2,17-dione |
| CAS Registry Number | 39156-67-7 |
| SMILES | CC1C2C(CC3=CC=CC=C3)NC(=O)C22OC(=O)CC(O)CCCC(C)C\C=C\C2C(O)C1=C |
| InChI Identifier | InChI=1S/C28H37NO5/c1-17-9-7-13-21(30)16-24(31)34-28-22(14-8-10-17)26(32)19(3)18(2)25(28)23(29-27(28)33)15-20-11-5-4-6-12-20/h4-6,8,11-12,14,17-18,21-23,25-26,30,32H,3,7,9-10,13,15-16H2,1-2H3,(H,29,33)/b14-8+ |
| InChI Key | InChIKey=ZFGBJIDXDYHNLX-RIYZIHGNSA-N |
| Chemical Taxonomy | |
| Kingdom | Organic Compounds |
| Super Class | Heterocyclic Compounds |
| Class | Isoindoles and Derivatives |
| Sub Class | Isoindlines |
| Direct Parent | Isoindolones |
| Alternative Parents |
|
| Molecular Framework | Aromatic Heteropolycyclic Compounds |
| Substituents |
|
| External Descriptors | Not Available |
| External Links | |
| DrugBank ID | Not Available |
| PubChem Compound ID | Not Available |
| KEGG ID | Not Available |
| UniProt ID | Not Available |
| OMIM ID | Not Available |
| ChEBI ID | Not Available |
| BioCyc ID | Not Available |
| CTD ID | Not Available |
| Stitch ID | Not Available |
| PDB ID | Not Available |
| ACToR ID | Not Available |
| Wikipedia Link | Not Available |
| Physical Properties | |
| Appearance | White powder. |
| Melting Point | 203-205C |
| Solubility | Not Available |
| Predicted LogP | 3.4066313553333334 |
| Toxicity Profile | |
| Route of Exposure | Oral, dermal, inhalation, and parenteral (contaminated drugs). (W967) |
| Mechanism of Action | Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W714, W715) |
| Metabolism | Not Available |
| Toxicity Values | Not Available |
| Lethal Dose | Not Available |
| Carcinogenicity (IARC Classification) | Not Available |
| Uses/Sources | Dihydrocytochalasin B is a semi-synthetic derivative of cytochalasin B and is a useful probe for studying cytochalasin binding sites. (W718) |
| Minimum Risk Level | Not Available |
| Health Effects | Major biological effects of cytochalasins include inhibition of the division of cytoplasm, reversible inhibition of cell movement, induction of nuclear extrusion, inhibition of such processes as phagocytosis, platelet aggregation and clot retraction, glucose transport, thyroid secretion, and release of growth hormone. Some cytochalasins have been shown to have developmental effects. (W718) |
| Symptoms | Not Available |
| Treatment | Consider activated charcoal after gastrointestinal absportion. Nitroprusside is recommended to reverse peripheral ischemia secondary to vasoconstriction and for the treatment of hypertension. Anticoagulant therapy with intravenous heparin is also recommended. (W574) |
| References | |
| General References |
|
Targets
1. Actin, alpha cardiac muscle 1
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W715)UniProt ID: P68032

Gene: ACTC1

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
2. Actin, alpha skeletal muscle
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W715)UniProt ID: P68133

Gene: ACTA1

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
3. Actin, aortic smooth muscle
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W715)UniProt ID: P62736

Gene: ACTA2

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
4. Actin, cytoplasmic 1
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W715)UniProt ID: P60709

Gene: ACTB

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
5. Actin, cytoplasmic 2
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W715)UniProt ID: P63261

Gene: ACTG1

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
6. Actin, gamma-enteric smooth muscle
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. (W713, W715)UniProt ID: P63267

Gene: ACTG2

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References: